These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32924431)

  • 61. The application of virus-like particles as vaccines and biological vehicles.
    Yan D; Wei YQ; Guo HC; Sun SQ
    Appl Microbiol Biotechnol; 2015 Dec; 99(24):10415-32. PubMed ID: 26454868
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Structure-Based Design of Porcine Circovirus Type 2 Chimeric VLPs (cVLPs) Displays Foreign Peptides on the Capsid Surface.
    Wang D; Zhang S; Zou Y; Yu W; Jiang Y; Zhan Y; Wang N; Dong Y; Yang Y
    Front Cell Infect Microbiol; 2018; 8():232. PubMed ID: 30038901
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Impacts on hepatitis B virus replication by gene engineering at apical loop region of capsid protein].
    Chen J; Huang R; Tao Y; Huang Y; Luo Y; Huang A; Hu J
    Sheng Wu Gong Cheng Xue Bao; 2013 Nov; 29(11):1663-71. PubMed ID: 24701831
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Modulation of the immunogenicity of virus-like particles composed of mutant hepatitis B virus envelope subunits.
    Cheong WS; Hyakumura M; Yuen L; Warner N; Locarnini S; Netter HJ
    Antiviral Res; 2012 Feb; 93(2):209-218. PubMed ID: 22138713
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Adjuvant effect of B domain of staphyloccocal protein A displayed on the surface of hepatitis B virus capsid.
    Kim HJ; Ahn KY; Bae KD; Lee J; Sim SJ; Lee J
    Biotechnol Bioeng; 2016 Feb; 113(2):268-74. PubMed ID: 26222886
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Improving the malaria transmission-blocking activity of a Plasmodium falciparum 48/45 based vaccine antigen by SpyTag/SpyCatcher mediated virus-like display.
    Singh SK; Thrane S; Janitzek CM; Nielsen MA; Theander TG; Theisen M; Salanti A; Sander AF
    Vaccine; 2017 Jun; 35(30):3726-3732. PubMed ID: 28578824
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Microbially synthesized modular virus-like particles and capsomeres displaying group A streptococcus hypervariable antigenic determinants.
    Chuan YP; Wibowo N; Connors NK; Wu Y; Hughes FK; Batzloff MR; Lua LH; Middelberg AP
    Biotechnol Bioeng; 2014 Jun; 111(6):1062-70. PubMed ID: 24338691
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Synthetic biology design to display an 18 kDa rotavirus large antigen on a modular virus-like particle.
    Lua LH; Fan Y; Chang C; Connors NK; Middelberg AP
    Vaccine; 2015 Nov; 33(44):5937-44. PubMed ID: 26387437
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Quaternary structure is critical for protein display on capsid-like particles (CLPs): efficient generation of hepatitis B virus CLPs presenting monomeric but not dimeric and tetrameric fluorescent proteins.
    Vogel M; Vorreiter J; Nassal M
    Proteins; 2005 Feb; 58(2):478-88. PubMed ID: 15526302
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Novel tissue and cell type-specific gene/drug delivery system using surface engineered hepatitis B virus nano-particles.
    Yamada T; Ueda M; Seno M; Kondo A; Tanizawa K; Kuroda S
    Curr Drug Targets Infect Disord; 2004 Jun; 4(2):163-7. PubMed ID: 15180463
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Preclinical refinements of a broadly protective VLP-based HPV vaccine targeting the minor capsid protein, L2.
    Tumban E; Muttil P; Escobar CA; Peabody J; Wafula D; Peabody DS; Chackerian B
    Vaccine; 2015 Jun; 33(29):3346-53. PubMed ID: 26003490
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Identification of an Immunogenic Mimic of a Conserved Epitope on the Plasmodium falciparum Blood Stage Antigen AMA1 Using Virus-Like Particle (VLP) Peptide Display.
    Crossey E; Frietze K; Narum DL; Peabody DS; Chackerian B
    PLoS One; 2015; 10(7):e0132560. PubMed ID: 26147502
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Production and characterization of novel ssRNA bacteriophage virus-like particles from metagenomic sequencing data.
    Liekniņa I; Kalniņš G; Akopjana I; Bogans J; Šišovs M; Jansons J; Rūmnieks J; Tārs K
    J Nanobiotechnology; 2019 May; 17(1):61. PubMed ID: 31084612
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Assessing stability and assembly of the hepatitis B surface antigen into virus-like particles during down-stream processing.
    Zahid M; Lünsdorf H; Rinas U
    Vaccine; 2015 Jul; 33(31):3739-45. PubMed ID: 26079614
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Potent neutralization activity against type O foot-and-mouth disease virus elicited by a conserved type O neutralizing epitope displayed on bovine parvovirus virus-like particles.
    Chang J; Zhang Y; Yang D; Jiang Z; Wang F; Yu L
    J Gen Virol; 2019 Feb; 100(2):187-198. PubMed ID: 30547855
    [TBL] [Abstract][Full Text] [Related]  

  • 76. High immunogenicity of a hydrophilic component of the hepatitis B virus preS1 sequence exposed on the surface of three virus-like particle carriers.
    Skrastina D; Bulavaite A; Sominskaya I; Kovalevska L; Ose V; Priede D; Pumpens P; Sasnauskas K
    Vaccine; 2008 Apr; 26(16):1972-81. PubMed ID: 18343539
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Virus-like particles displaying envelope domain III of dengue virus type 2 induce virus-specific antibody response in mice.
    Arora U; Tyagi P; Swaminathan S; Khanna N
    Vaccine; 2013 Jan; 31(6):873-8. PubMed ID: 23261049
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Feasibility of Cowpea chlorotic mottle virus-like particles as scaffold for epitope presentations.
    Hassani-Mehraban A; Creutzburg S; van Heereveld L; Kormelink R
    BMC Biotechnol; 2015 Aug; 15():80. PubMed ID: 26311254
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Engineering the HK97 virus-like particle as a nanoplatform for biotechnology applications.
    Woods MD; Cali M; Ceesay B; Fancher S; Ibrasheva G; Kandeel S; Nassar M; Azghani A; Bill B; Patterson DP
    J Mater Chem B; 2023 Jul; 11(26):6060-6074. PubMed ID: 37345352
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The Dual Role of an ESCRT-0 Component HGS in HBV Transcription and Naked Capsid Secretion.
    Chou SF; Tsai ML; Huang JY; Chang YS; Shih C
    PLoS Pathog; 2015 Oct; 11(10):e1005123. PubMed ID: 26431433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.